BAKER BROS. ADVISORS LP Q2 2024 Filing
Filed August 14, 2024
Portfolio Value
$7825.1T
Holdings
95
Report Date
Q2 2024
Filing Type
13F-HR
All Holdings (95 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | INCYIncyte Corporation | 30,738,524 | $1863.4T | 23.81% | |
| 2 | ONCBeiGene, Ltd. | 10,568,897 | $1507.9T | 19.27% | |
| 3 | ACADACADIA Pharmaceuticals Inc. | 42,877,916 | $696.8T | 8.90% | |
| 4 | MDGLMadrigal Pharmaceuticals, Inc. | 1,974,590 | $553.2T | 7.07% | |
| 5 | RVMDRevolution Medicines, Inc. | 7,569,090 | $293.8T | 3.75% | |
| 6 | RYTMRhythm Pharmaceuticals, Inc. | 6,398,365 | $262.7T | 3.36% | |
| 7 | IM8NInsmed Incorporated | 3,576,038 | $239.6T | 3.06% | |
| 8 | BCYCBicycle Therapeutics plc | 9,399,960 | $190.3T | 2.43% | |
| 9 | SMMTSummit Therapeutics Inc. | 23,222,222 | $181.1T | 2.31% | |
| 10 | KYMRKymera Therapeutics, Inc. | 5,995,928 | $179.0T | 2.29% | |
| 11 | EWTXEdgewise Therapeutics, Inc. | 5,840,059 | $105.2T | 1.34% | |
| 12 | ALKSAlkermes plc | 4,181,751 | $100.8T | 1.29% | |
| 13 | INSM 0.75 06/01/28Insmed Incorporated | 42,850,000 | $90.4T | 1.16% | |
| 14 | REPLReplimune Group, Inc. | 10,045,336 | $90.4T | 1.16% | |
| 15 | DNLIDenali Therapeutics Inc. | 3,731,695 | $86.6T | 1.11% | |
| 16 | ABCLAbCellera Biologics Inc. | 27,525,640 | $81.5T | 1.04% | |
| 17 | NRIXNurix Therapeutics, Inc. | 3,882,125 | $81.0T | 1.04% | |
| 18 | IMTXImmatics N.V. | 6,443,398 | $74.9T | 0.96% | |
| 19 | TRDAEntrada Therapeutics, Inc. | 4,865,819 | $69.3T | 0.89% | |
| 20 | RAREUltragenyx Pharmaceutical Inc. | 1,466,547 | $60.3T | 0.77% | |
| 21 | STOKStoke Therapeutics, Inc. | 4,368,443 | $59.0T | 0.75% | |
| 22 | INSM 1.75 01/15/25Insmed Incorporated | 32,887,000 | $56.2T | 0.72% | |
| 23 | KNSAKiniksa Pharmaceuticals International, plc | 2,818,323 | $52.6T | 0.67% | |
| 24 | IMCRImmunocore Holdings plc | 1,515,318 | $51.4T | 0.66% | |
| 25 | ARGXargenx SE | 111,904 | $48.1T | 0.61% | |
| 26 | KODKodiak Sciences Inc. | 17,310,490 | $40.7T | 0.52% | |
| 27 | XENEXenon Pharmaceuticals Inc. | 993,679 | $38.7T | 0.50% | |
| 28 | PRLDPrelude Therapeutics Inc. | 10,123,824 | $38.6T | 0.49% | |
| 29 | IDYAIDEAYA Biosciences, Inc. | 1,062,123 | $37.3T | 0.48% | |
| 30 | CERSCerus Corporation | 19,477,339 | $34.3T | 0.44% | |
| 31 | SERASera Prognostics, Inc. | 5,434,399 | $32.2T | 0.41% | |
| 32 | KRYSKrystal Biotech, Inc. | 169,934 | $31.2T | 0.40% | |
| 33 | CELCCelcuity Inc. | 1,874,978 | $30.7T | 0.39% | |
| 34 | ROIVRoivant Sciences Ltd. | 2,798,716 | $29.6T | 0.38% | |
| 35 | 1K0IGM Biosciences, Inc. | 4,090,316 | $28.1T | 0.36% | |
| 36 | CERE1EURCerevel Therapeutics Holdings, Inc. | 683,588 | $28.0T | 0.36% | |
| 37 | AKROAkero Therapeutics, Inc. | 1,097,082 | $25.7T | 0.33% | |
| 38 | DYNDyne Therapeutics, Inc. | 672,096 | $23.7T | 0.30% | |
| 39 | ALMSAlumis Inc. | 1,562,500 | $20.8T | 0.27% | |
| 40 | GLUEMonte Rosa Therapeutics, Inc. | 4,916,095 | $18.4T | 0.23% | |
| 41 | MRUSMerus N.V. | 300,000 | $17.8T | 0.23% | |
| 42 | NGNENeurogene Inc. | 456,015 | $16.6T | 0.21% | |
| 43 | TCRXTScan Therapeutics, Inc. | 2,784,792 | $16.3T | 0.21% | |
| 44 | SANASana Biotechnology, Inc. | 2,380,949 | $13.0T | 0.17% | |
| 45 | IMVTImmunovant, Inc. | 464,718 | $12.3T | 0.16% | |
| 46 | XNCRXencor, Inc. | 545,431 | $10.3T | 0.13% | |
| 47 | NMRANeumora Therapeutics, Inc. | 1,034,600 | $10.2T | 0.13% | |
| 48 | FATEFate Therapeutics, Inc. | 2,997,772 | $9.8T | 0.13% | |
| 49 | TSVT*2seventy bio, Inc. | 2,497,526 | $9.6T | 0.12% | |
| 50 | BMEABiomea Fusion, Inc. | 2,108,949 | $9.5T | 0.12% | |
| 51 | TCE2Celldex Therapeutics, Inc. | 247,644 | $9.2T | 0.12% | |
| 52 | TSHATaysha Gene Therapies, Inc. | 4,004,756 | $9.0T | 0.11% | |
| 53 | —Athira Pharma, Inc. | 3,153,807 | $8.4T | 0.11% | |
| 54 | VERVVerve Therapeutics, Inc. | 1,691,530 | $8.3T | 0.11% | |
| 55 | RLAYRelay Therapeutics, Inc. | 1,160,117 | $7.6T | 0.10% | |
| 56 | MIRMMirum Pharmaceuticals, Inc. | 190,476 | $6.5T | 0.08% | |
| 57 | TNGXTango Therapeutics, Inc. | 750,000 | $6.4T | 0.08% | |
| 58 | KALAKALA BIO, Inc. | 891,335 | $6.3T | 0.08% | |
| 59 | DBVTDBV Technologies S.A. | 7,307,131 | $5.9T | 0.07% | |
| 60 | DSGNDesign Therapeutics, Inc. | 1,695,294 | $5.7T | 0.07% | |
| 61 | CTNMContineum Therapeutics, Inc. | 312,500 | $5.5T | 0.07% | |
| 62 | PRAXPraxis Precision Medicines, Inc. | 131,533 | $5.4T | 0.07% | |
| 63 | CRSPCRISPR Therapeutics AG | 100,000 | $5.4T | 0.07% | |
| 64 | PRMEPrime Medicine, Inc. | 1,028,466 | $5.3T | 0.07% | |
| 65 | CNTACentessa Pharmaceuticals plc | 549,212 | $5.0T | 0.06% | |
| 66 | HOOKHOOKIPA Pharma Inc. | 8,128,151 | $4.8T | 0.06% | |
| 67 | SGMTSagimet Biosciences Inc. | 1,381,898 | $4.7T | 0.06% | |
| 68 | CRNXCrinetics Pharmaceuticals, Inc. | 103,927 | $4.7T | 0.06% | |
| 69 | TLISTalis Biomedical Corporation | 508,323 | $4.4T | 0.06% | |
| 70 | ALECAlector, Inc. | 927,264 | $4.2T | 0.05% | |
| 71 | OPTEYOpthea Limited | 2,173,622 | $4.2T | 0.05% | |
| 72 | SKYESkye Bioscience, Inc. | 500,000 | $4.0T | 0.05% | |
| 73 | PCVXVaxcyte, Inc. | 48,885 | $3.7T | 0.05% | |
| 74 | ARCTArcturus Therapeutics Holdings Inc. | 151,329 | $3.7T | 0.05% | |
| 75 | GBIOGBXGeneration Bio Co. | 1,206,957 | $3.4T | 0.04% | |
| 76 | ELVNEnliven Therapeutics, Inc. | 114,833 | $2.7T | 0.03% | |
| 77 | CYPHLeap Therapeutics, Inc. | 1,172,175 | $2.3T | 0.03% | |
| 78 | ADAPYAdaptimmune Therapeutics plc | 2,343,695 | $2.3T | 0.03% | |
| 79 | —Mersana Therapeutics, Inc. | 1,086,115 | $2.2T | 0.03% | |
| 80 | IPSCCentury Therapeutics, Inc. | 797,460 | $2.0T | 0.03% | |
| 81 | NAMSNewAmsterdam Pharma Company N.V. | 96,827 | $1.9T | 0.02% | |
| 82 | SG7Sage Therapeutics, Inc. | 171,026 | $1.9T | 0.02% | |
| 83 | VTVTvTv Therapeutics, Inc. | 97,314 | $1.7T | 0.02% | |
| 84 | CMPXCompass Therapeutics, Inc. | 1,557,630 | $1.6T | 0.02% | |
| 85 | TARAProtara Therapeutics, Inc. | 536,832 | $1.1T | 0.01% | |
| 86 | AVTEAerovate Therapeutics, Inc. | 628,939 | $1.0T | 0.01% | |
| 87 | PFEPfizer Inc. | 35,000 | $979.3B | 0.01% | |
| 88 | 698Achilles Therapeutics plc | 1,108,767 | $903.6B | 0.01% | |
| 89 | ALGSAligos Therapeutics, Inc. | 2,076,400 | $726.7B | 0.01% | |
| 90 | PMVPPMV Pharmaceuticals, Inc. | 322,024 | $521.7B | 0.01% | |
| 91 | BCRXBioCryst Pharmaceuticals, Inc. | 75,778 | $468.3B | 0.01% | |
| 92 | ACRVAcrivon Therapeutics, Inc. | 52,885 | $306.7B | 0.00% | |
| 93 | FHTXFoghorn Therapeutics Inc. | 45,027 | $258.9B | 0.00% | |
| 94 | TYRATyra Biosciences, Inc. | 10,607 | $169.6B | 0.00% | |
| 95 | SRZNWSurrozen, Inc. | 833,333 | $13.8B | 0.00% |